Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
M B BignellAkash M MehtaS AlvesK ChandrakumaranS P DayalF MohamedT D CecilB J MoranPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2019)
Women with ovarian metastases from low-grade appendiceal tumours or colorectal cancer treated with CRS and HIPEC have similar survival rates to patients without ovarian metastases. Long-term survival and cure is feasible in patients amenable to complete tumour removal.